Return on Retained Earnings (RORE) is an indicator of a company's growth potential, it shows how much a company earns by reinvesting its retained earnings, i.e. profits after dividend payments.
SANUWAVE Health's 5-Year RORE % for the quarter that ended in Mar. 2026 was -52.36%.
The industry rank for SANUWAVE Health's 5-Year RORE % or its related term are showing as below:
SNWV's 5-Year RORE % is ranked worse than 85.19% of 702
companies
in the Medical Devices & Instruments industry
Industry Median: -5.03
vs SNWV: -52.36
SANUWAVE Health (NAS:SNWV) 5-Year RORE % Explanation
Return on Retained Earnings (RORE) is important to investors because it reveals a company's efficiency and growth potential. A higher RORE indicates a higher return. A high RORE indicates that the company should reinvest profits into the business. A lower RORE suggests that the company should distribute profits to shareholders by paying out dividends, since those dollars aren't generating much additional growth for the company.
There are a several different ways to arrive at the Return on Retained Earnings. The simplest way to calculate it is by using published information on Earnings per Share (EPS) and Dividend per Share (DPS) over a selected period. Here, 5-year period is chosen.
Be Aware
Please keep in mind that the RORE is relative to the nature of the business and its competitors. If another company in the same sector is producing a lower return on retained earnings, it doesn’t necessarily mean it’s a bad investment. It may just suggest the company is older and no longer in a high growth stage. At such a stage in the business cycle, it would be expected to see a lower RORE and higher dividend payout.
SANUWAVE Health 5-Year RORE % Related Terms
SANUWAVE Health 5-Year RORE % Historical Data
* Premium members only.
The historical data trend for SANUWAVE Health's 5-Year RORE % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
SNWV vs RTGN, NNOX, LNSR: 5-Year RORE % Comparison
For the Medical Devices subindustry, SANUWAVE Health's 5-Year RORE %, along with its competitors' market caps and 5-Year RORE % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
SANUWAVE Health 5-Year RORE % vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, SANUWAVE Health's 5-Year RORE % distribution charts can be found below:
* The bar in red indicates where SANUWAVE Health's 5-Year RORE % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
In the calculation of 5-Year RORE %, the most recent and first period EPS (Diluted) is the trailing twelve months (TTM) data ended in Mar. 2026 and 5-year before.
SANUWAVE Health (SNWV) has a 5-Year RORE % of -52.36 as of Mar. 2026. 5-Year RORE % shows how much a company earns by reinvesting its retained earnings in 5-year. View historical data on SANUWAVE Health and its competitors. According to the industry distribution chart, SANUWAVE Health ranks #598 out of 702 companies in the Medical Devices & Instruments industry, placing it in the top 85.2%.
Is SANUWAVE Health's 5-Year RORE % too high?
SANUWAVE Health's current 5-Year RORE % is -52.36. Based on the distribution chart, SANUWAVE Health ranks #598 out of 702 companies in the Medical Devices & Instruments industry, which is in the bottom quartile relative to peers. Overall, SANUWAVE Health has a GF Score™ of 38/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does SANUWAVE Health's 5-Year RORE % compare to RTGN and NNOX?
According to the Medical Devices & Instruments industry distribution chart, SANUWAVE Health ranks #598 out of 702 companies for 5-Year RORE %. This places SANUWAVE Health in the lower half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 5-Year RORE % for a Medical Devices & Instruments company?
A good 5-Year RORE % depends on the Medical Devices & Instruments industry context. However, 5-Year RORE % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 5-Year RORE % mean?
A high 5-Year RORE % can signal that a stock is expensive relative to its fundamentals. 5-Year RORE % shows how much a company earns by reinvesting its retained earnings in 5-year. View historical data on SANUWAVE Health and its competitors. SANUWAVE Health's current 5-Year RORE % is -52.36. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is SANUWAVE Health stock overvalued right now?
Based on GuruFocus' analysis, SANUWAVE Health (SNWV) is currently considered Fairly Valued. The stock's GF Value™ is $12.02, compared to a current price of $11.71 — trading 2.6% below its estimated fair value. The current 5-Year RORE % is -52.36. SANUWAVE Health's overall GF Score™ is 38/100 with 8 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 5-Year RORE % calculated?
5-Year RORE % is calculated from a company's financial statements. For SANUWAVE Health (SNWV), the current 5-Year RORE % is -52.36 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is SANUWAVE Health (SNWV) Overvalued in 2026?
Based on GuruFocus' analysis, SANUWAVE Health stock appears to be undervalued.
The current stock price of $11.71 is trading 2.6% below its estimated GF Value™ of $12.02.
GuruFocus considers SANUWAVE Health to be Fairly Valued.
Key valuation signals for SNWV:
5-Year RORE %: -52.36
GF Value™: $12.02 vs. price of $11.71 (2.6% below fair value)
No single metric tells the full story. See the SNWV stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
SANUWAVE Health Inc is a medical device company providing directed energy products into the wound care space. It is focused on the commercialization of its patented regenerative medicine utilizing noninvasive ultrasound or shockwaves to produce a biological response promoting the repair and regeneration of tissue, musculoskeletal, and vascular structures. Sanuwave's patented, FDA-cleared, and commercialised product is the UltraMIST system, which is used to treat a variety of acute and chronic wounds using ultrasound technology. The company operates in one reportable segment, the design and sale of medical devices. Geographically, the company generates revenue mainly from the United States.
38GF Score
Get the complete analysis for SNWV
5-Year RORE % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SNWV has been successfully added to your 
